Rindex obtains license for AF prediction technology

05/1/2013 | MedCityNews.com

Rindex Medical has gained exclusive license from the Cleveland Clinic to develop the A-50 AF Prediction System, a tool that doctors can use to predict a patient's risk for atrial fibrillation after cardiac surgery. The Redwood City, Calif.-based startup has a working prototype of the device and is preparing to apply for 510(k) clearance.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ